Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2018

Open Access 01-12-2018 | Research article

Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study

Authors: Morten Malmborg, Christine Benn Christiansen, Michelle D. Schmiegelow, Christian Torp-Pedersen, Gunnar Gislason, Morten Schou

Published in: BMC Cardiovascular Disorders | Issue 1/2018

Login to get access

Abstract

Background

Few studies have suggested that patients with myocardial infarction (MI) may be at increased risk of cancer, but further large register-based studies are needed to evaluate this subject. The aim of this study was to assess the incident rates of cancer and death by history of MI, and whether an MI is independently associated with cancer in a large cohort study.

Method

All Danish residents aged 30–99 in 1996 without prior cancer or MI were included and were followed until 2012. Patients were grouped according to incident MI during follow-up. Incidence rates (IR) of cancer and death in individuals with and without MI and incidence rate ratios (IRR, using multivariable Poisson regression analyses) of cancer associated with an MI were calculated.

Results

Of 2,871,168 individuals, 122,275 developed an MI during follow-up, 11,375 subsequently developed cancer (9.3%, IR 19.1/1000 person-years) and 65,225 died (53.3%, IR 106.0/1000 person-years). In the reference population, 372,397 developed cancer (13.0%, IR 9.3/1000 person-years) and 753,767 died (26.3%, IR 18.2/1000 person-years). Compared to the reference population, higher IRs of cancer and death were observed in all age groups (30–54, 55–69 and 70–99 years) and time since an MI (0–1, 1–5 and 5–17 years) in the MI population. MI was associated with an increased risk of overall cancer (IRR 1.14, 95% CI 1.10–1.19) after adjusting for age, sex and calendar year, also when additionally adjusting for chronic obstructive pulmonary disease, hypertension, dyslipidemia, diabetes and socioeconomic status (IRR 1.08, 95% CI 1.03–1.13), but not after further adjustment for the first 6 months post-MI (IRR 1.00, 95% CI 0.96–1.05).

Conclusion

Patients after an MI have increased incidence of cancer, which may be explained by mutual risk, occult cancers and increased surveillance. Focus on risk factor management to reduce cancer and MI is warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950–9.CrossRef Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2950–9.CrossRef
2.
go back to reference Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.CrossRef Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.CrossRef
3.
go back to reference Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008;51(13):1247–54.CrossRef Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol. 2008;51(13):1247–54.CrossRef
4.
go back to reference Orozco-Beltran D, Cooper RS, Gil-Guillen V, Bertomeu-Martinez V, Pita-Fernandez S, Durazo-Arvizu R, et al. Trends in mortality from myocardial infarction. A comparative study between Spain and the United States: 1990-2006. Rev Esp Cardiol Engl Ed. 2012;65(12):1079–85.CrossRef Orozco-Beltran D, Cooper RS, Gil-Guillen V, Bertomeu-Martinez V, Pita-Fernandez S, Durazo-Arvizu R, et al. Trends in mortality from myocardial infarction. A comparative study between Spain and the United States: 1990-2006. Rev Esp Cardiol Engl Ed. 2012;65(12):1079–85.CrossRef
5.
go back to reference Spoon DB, Psaltis PJ, Singh M, Holmes DR, Gersh BJ, Rihal CS, et al. Trends in cause of death after percutaneous coronary intervention. Circulation. 2014;129(12):1286–94.CrossRef Spoon DB, Psaltis PJ, Singh M, Holmes DR, Gersh BJ, Rihal CS, et al. Trends in cause of death after percutaneous coronary intervention. Circulation. 2014;129(12):1286–94.CrossRef
6.
go back to reference Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64(20):2101–8.CrossRef Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J Am Coll Cardiol. 2014;64(20):2101–8.CrossRef
7.
go back to reference Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, et al. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013;62(10):881–6.CrossRef Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, et al. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013;62(10):881–6.CrossRef
8.
go back to reference Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344(8925):793–5.CrossRef Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;344(8925):793–5.CrossRef
9.
go back to reference Hansen ES. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis--a review of the epidemiological evidence. Mutat Res. 1990;239(3):163–79.CrossRef Hansen ES. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis--a review of the epidemiological evidence. Mutat Res. 1990;239(3):163–79.CrossRef
11.
go back to reference Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and Cancer. Circulation. 2016;133(11):1104–14.CrossRef Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and Cancer. Circulation. 2016;133(11):1104–14.CrossRef
12.
go back to reference Lip GYH, Chin BSP, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27–34.CrossRef Lip GYH, Chin BSP, Blann AD. Cancer and the prothrombotic state. Lancet Oncol. 2002;3(1):27–34.CrossRef
13.
go back to reference Naschitz JE, Yeshurun D, Abrahamson J. Arterial occlusive disease in occult cancer. Am Heart J. 1992;124(3):738–45.CrossRef Naschitz JE, Yeshurun D, Abrahamson J. Arterial occlusive disease in occult cancer. Am Heart J. 1992;124(3):738–45.CrossRef
14.
go back to reference Dreyer L, Olsen JH. Cancer risk of patients discharged with acute myocardial infarct. Epidemiol Camb Mass. 1998;9(2):178–83.CrossRef Dreyer L, Olsen JH. Cancer risk of patients discharged with acute myocardial infarct. Epidemiol Camb Mass. 1998;9(2):178–83.CrossRef
15.
go back to reference Pehrsson SK, Linnersjö A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Intern Med. 2005;258(2):124–32.CrossRef Pehrsson SK, Linnersjö A, Hammar N. Cancer risk of patients with ischaemic syndromes. J Intern Med. 2005;258(2):124–32.CrossRef
16.
go back to reference Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, et al. Myocardial infarction and future risk of cancer in the general population-the Tromsø study. Eur J Epidemiol. 2017;32(3):193–201.CrossRef Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, et al. Myocardial infarction and future risk of cancer in the general population-the Tromsø study. Eur J Epidemiol. 2017;32(3):193–201.CrossRef
17.
go back to reference Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124–30.CrossRef Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124–30.CrossRef
18.
go back to reference Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of patients. BMC Med Res Methodol. 2011;11:83.CrossRef Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of patients. BMC Med Res Methodol. 2011;11:83.CrossRef
19.
go back to reference Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P. Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014;61(2):A4777.PubMed Larsen MB, Jensen H, Hansen RP, Olesen F, Vedsted P. Identification of patients with incident cancers using administrative registry data. Dan Med J. 2014;61(2):A4777.PubMed
20.
go back to reference Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.CrossRef Olesen JB, Lip GYH, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011;342:d124.CrossRef
21.
go back to reference Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117(15):1945–54.CrossRef Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation. 2008;117(15):1945–54.CrossRef
22.
go back to reference Andersson C, Vaag A, Selmer C, Schmiegelow M, Sørensen R, Lindhardsen J, et al. Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people. BMJ Open. 2012;2(3):e000433.CrossRef Andersson C, Vaag A, Selmer C, Schmiegelow M, Sørensen R, Lindhardsen J, et al. Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people. BMJ Open. 2012;2(3):e000433.CrossRef
24.
go back to reference Berger SM, Gislason G, Moore LL, Andersson C, Torp-Pedersen C, Denis GV, et al. Associations between metabolic disorders and risk of cancer in Danish men and women - a nationwide cohort study. BMC Cancer. 2016;16(1):133.CrossRef Berger SM, Gislason G, Moore LL, Andersson C, Torp-Pedersen C, Denis GV, et al. Associations between metabolic disorders and risk of cancer in Danish men and women - a nationwide cohort study. BMC Cancer. 2016;16(1):133.CrossRef
25.
go back to reference Eyre H, Kahn R, Robertson RM. Preventing Cancer, cardiovascular disease, and diabetes a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care. 2004;27(7):1812–24.CrossRef Eyre H, Kahn R, Robertson RM. Preventing Cancer, cardiovascular disease, and diabetes a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care. 2004;27(7):1812–24.CrossRef
26.
go back to reference Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.CrossRef Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.CrossRef
27.
go back to reference Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S–60S.CrossRef Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006;83(2):456S–60S.CrossRef
28.
go back to reference Hasin T, Gerber Y, Weston SA, Jiang R, Killian JM, Manemann SM, et al. Heart failure after myocardial infarction is associated with increased risk of Cancer. J Am Coll Cardiol. 2016;68(3):265–71.CrossRef Hasin T, Gerber Y, Weston SA, Jiang R, Killian JM, Manemann SM, et al. Heart failure after myocardial infarction is associated with increased risk of Cancer. J Am Coll Cardiol. 2016;68(3):265–71.CrossRef
30.
go back to reference Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30–3.CrossRef Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30–3.CrossRef
31.
go back to reference Helqvist L, Erichsen R, Gammelager H, Johansen MB, Sørensen HT. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of patients. Eur J Cancer Care (Engl). 2012;21(6):722–7.CrossRef Helqvist L, Erichsen R, Gammelager H, Johansen MB, Sørensen HT. Quality of ICD-10 colorectal cancer diagnosis codes in the Danish National Registry of patients. Eur J Cancer Care (Engl). 2012;21(6):722–7.CrossRef
32.
go back to reference Gammelager H, Christiansen CF, Johansen MB, Borre M, Schoonen M, Sørensen HT. Quality of urological cancer diagnoses in the Danish National Registry of patients. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2012;21(6):545–51.CrossRef Gammelager H, Christiansen CF, Johansen MB, Borre M, Schoonen M, Sørensen HT. Quality of urological cancer diagnoses in the Danish National Registry of patients. Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. 2012;21(6):545–51.CrossRef
Metadata
Title
Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study
Authors
Morten Malmborg
Christine Benn Christiansen
Michelle D. Schmiegelow
Christian Torp-Pedersen
Gunnar Gislason
Morten Schou
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2018
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-018-0932-z

Other articles of this Issue 1/2018

BMC Cardiovascular Disorders 1/2018 Go to the issue